Back
LSB Industries 10K Form
Sell
40
LXU
LSB Industries
Last Price:
7.52
Seasonality Move:
-5.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | LXU/LSB Industries Quarterly |
2023-11-02 | 10Q | LXU/LSB Industries Quarterly |
2023-07-27 | 10Q | LXU/LSB Industries Quarterly |
2023-05-03 | 10Q | LXU/LSB Industries Quarterly |
2022-11-02 | 10Q | LXU/LSB Industries Quarterly |
2022-07-28 | 10Q | LXU/LSB Industries Quarterly |
Receive LXU News And Ratings
See the #1 stock for the next 7 days that we like better than LXU
LXU Financial Statistics
Sales & Book Value
Annual Sales: | $593.71M |
---|---|
Cash Flow: | $26.62M |
Price / Cash Flow: | 17.1 |
Annual Sales: | $7.29 |
Price / Book: | 1.01 |
Profitability
EPS (TTM): | 0.04000 |
---|---|
Net Income (TTM): | $2.11M |
Gross Margin: | $86.26M |
Return on Equity: | 0.4% |
Return on Assets: | 0.17% |
LSB Industries Earnings Forecast
Key LSB Industries Financial Ratios
- The Gross Profit Margin over the past 40 years for LXU is 14.53%.
- The Selling, General & Administrative Expenses for LXU have been equal to 6.16% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 147.32% of Operating Income.
- The Net Earning history of LXU is 4.70% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 19 years.
LSB Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | LXU |
CUSIP: | 502160 |
Website: | lsbindustries.com |
Debt
Debt-to-Equity Ratio: | 0.94 |
---|---|
Current Ratio: | 3.41 |
Quick Ratio: | 2.65 |
Price-to-Earnings
Trailing P/E Ratio: | 19.97 |
---|---|
Forward P/E Ratio: | 16.75 |
LXU Technical Analysis vs Fundamental Analysis
Sell
40
LSB Industries (LXU)
is a Sell
Is LSB Industries a Buy or a Sell?
-
LSB Industries stock is rated a Sell
The current LSB Industries [LXU] share price is $7.39. The Score for LXU is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.